152 related articles for article (PubMed ID: 24379989)
1. Effect of flupirtine on the growth and viability of U373 malignant glioma cells.
Panchanathan E; Ramanathan G; Lakkakula BV
Cancer Biol Med; 2013 Sep; 10(3):142-7. PubMed ID: 24379989
[TBL] [Abstract][Full Text] [Related]
2. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound.
Klawe C; Maschke M
Expert Opin Pharmacother; 2009 Jun; 10(9):1495-500. PubMed ID: 19505216
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of flupirtine in subacute/ chronic musculoskeletal pain - results of a patient level, pooled re-analysis of randomized, double-blind, controlled trials.
Ueberall MA; Mueller-Schwefe GH; Terhaag B
Int J Clin Pharmacol Ther; 2011 Nov; 49(11):637-47. PubMed ID: 22011688
[TBL] [Abstract][Full Text] [Related]
4. Flupirtine, a nonopioid centrally acting analgesic, acts as an NMDA antagonist.
Osborne NN; Cazevieille C; Wood JP; Nash MS; Pergande G; Block F; Kosinski C; Schwarz M
Gen Pharmacol; 1998 Mar; 30(3):255-63. PubMed ID: 9510072
[TBL] [Abstract][Full Text] [Related]
5. Influence of flupirtine on a G-protein coupled inwardly rectifying potassium current in hippocampal neurones.
Jakob R; Krieglstein J
Br J Pharmacol; 1997 Dec; 122(7):1333-8. PubMed ID: 9421279
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant properties of the triaminopyridine, flupirtine.
Gassen M; Pergande G; Youdim MB
Biochem Pharmacol; 1998 Nov; 56(10):1323-9. PubMed ID: 9825731
[TBL] [Abstract][Full Text] [Related]
7. Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Kornhuber J; Bleich S; Wiltfang J; Maler M; Parsons CG
J Neural Transm (Vienna); 1999; 106(9-10):857-67. PubMed ID: 10599868
[TBL] [Abstract][Full Text] [Related]
8. Flupirtine reduces functional deficits and neuronal damage after global ischemia in rats.
Block F; Pergande G; Schwarz M
Brain Res; 1997 Apr; 754(1-2):279-84. PubMed ID: 9134985
[TBL] [Abstract][Full Text] [Related]
9. The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1.
Perovic S; Schleger C; Pergande G; Iskric S; Ushijima H; Rytik P; Müller WE
Eur J Pharmacol; 1994 Dec; 288(1):27-33. PubMed ID: 7705465
[TBL] [Abstract][Full Text] [Related]
10. Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drug-mediated anti-apoptotic effect.
Perovic S; Pialoglou P; Schröder HC; Pergande G; Müller WE
Eur J Pharmacol; 1996 Dec; 317(1):157-64. PubMed ID: 8982732
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in cultured human retinal pigment epithelial cells is counteracted by flupirtine.
Osborne NN; Cazevieille C; Pergande G; Wood JP
Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1390-400. PubMed ID: 9191602
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate (NMDA)-mediated muscle relaxant action of flupirtine in rats.
Schwarz M; Block F; Pergande G
Neuroreport; 1994 Oct; 5(15):1981-4. PubMed ID: 7841390
[TBL] [Abstract][Full Text] [Related]
13. Flupirtine and retigabine prevent L-glutamate toxicity in rat pheochromocytoma PC 12 cells.
Seyfried J; Evert BO; Rundfeldt C; Schulz JB; Kovar KA; Klockgether T; Wüllner U
Eur J Pharmacol; 2000 Jul; 400(2-3):155-66. PubMed ID: 10988329
[TBL] [Abstract][Full Text] [Related]
14. Antiparkinsonian effect of flupirtine in monoamine-depleted rats.
Schwarz M; Nolden-Koch M; Purr J; Pergande G; Block F
J Neural Transm (Vienna); 1996; 103(5):581-90. PubMed ID: 8811503
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacologic effect of flupirtine, a structurally new analgesic].
Jakovlev V; Sofia RD; Achterrath-Tuckermann U; von Schlichtegroll A; Thiemer K
Arzneimittelforschung; 1985; 35(1):30-43. PubMed ID: 2985093
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of flupirtine modified release for the management of moderate to severe chronic low back pain: results of SUPREME, a prospective randomized, double-blind, placebo- and active-controlled parallel-group phase IV study.
Uberall MA; Mueller-Schwefe GH; Terhaag B
Curr Med Res Opin; 2012 Oct; 28(10):1617-34. PubMed ID: 22970658
[TBL] [Abstract][Full Text] [Related]
17. Flupirtine in pain management: pharmacological properties and clinical use.
Devulder J
CNS Drugs; 2010 Oct; 24(10):867-81. PubMed ID: 20839897
[TBL] [Abstract][Full Text] [Related]
18. The evolving understanding of the analgesic mechanism of action of flupirtine.
Raffa RB; Pergolizzi JV
J Clin Pharm Ther; 2012 Feb; 37(1):4-6. PubMed ID: 21114508
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation.
Gassen M; Lamensdorf I; Armony T; Finberg JP; Youdim MB
J Neural Transm (Vienna); 2003 Feb; 110(2):171-82. PubMed ID: 12589576
[TBL] [Abstract][Full Text] [Related]
20. Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration.
Rupalla K; Cao W; Krieglstein J
Eur J Pharmacol; 1995 Dec; 294(2-3):469-73. PubMed ID: 8750707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
